Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1

ClinicalTrials.gov ID: NCT00032929

Public ClinicalTrials.gov record NCT00032929. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 1:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the Selegiline Transdermal System for the treatment of cocaine dependence.

Study identification

NCT ID
NCT00032929
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
269 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2001 (Type not available)
Primary completion
Dec 2002 (Actual)
Completion
Not listed
Last update posted
Jan 12, 2017

Started 2001

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
14
Facility City State ZIP Site status
Tucson VA Medical Center Tucson Arizona 85723 —
Haight-Ashbury Free Clinic Berkeley California 94704 —
Friends Research Institute-2 Los Angeles California 90025 —
Friends Research Institute Los Angeles California 90025 —
San Francisco General Hosptial San Francisco California 94110 —
San Francisco VA Medical Center San Francisco California 94121 —
Denver VA Medical Center Denver Colorado 80220 —
New Orleans VA Medical Center New Orleans Louisiana 70112 —
VA Maryland Healthcare System Baltimore Maryland 21201 —
Wayne State University Detroit Michigan 48207 —
Cincinnati VA Medical Center Cincinnati Ohio 45220 —
Medical University of South Carolina Charleston South Carolina 29425 742 —
VA North Texas Health Care System Dallas Texas 75216 —
University of Texas Hlth Sci Ctr Houston Houston Texas 77030 —
Salt Lake City VA Medical Center Salt Lake City Utah 84148 —
VA Puget Sound Health Care System Seattle Washington 98108 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00032929, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 12, 2017 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00032929 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →